Literature DB >> 8103192

The effectiveness of beta-adrenoceptor stimulation and the contribution of beta 1-adrenoceptors increase from the proximal to the distal part of the canine saphenous vein.

S Guimarães1, A Mota, R Begonha.   

Abstract

The present study was undertaken to characterize beta-adrenoceptors of the canine saphenous vein and their distribution along this vessel. In a first series of experiments, concentration-response curves to isoprenaline and forskolin were compared on strips taken from proximal and distal portions of the vein. The tone of the strip was previously increased by phenylephrine to one of the three levels: about 85, 70 and 55% of the maximum, which corresponds to 3.08 +/- 0.16 and 2.96 +/- 0.17 (n = 6) N.g-1, for proximal and distal strips, respectively. The maximal relaxation to isoprenaline was significantly larger in the distal than in the proximal portion, for responses starting at 85 and 70% of the maximum tone. In contrast, forskolin caused 100% relaxation, both proximally and distally, irrespective of the previous tone. In a second series of experiments, the relaxation to dobutamine and terbutaline was compared in proximal and distal portions after the tone had been elevated by adrenaline, noradrenaline and phenylephrine to about 70% of the maximum. When the tone was increased by adrenaline, the relaxation in response to 2.7 mumol.l-1 dobutamine was larger than that to 2.7 mumol.l-1 terbutaline both in proximal and distal portions, while when it was increased by noradrenaline, the relaxation to terbutaline was larger than that to dobutamine in the proximal portion; in the distal portion, dobutamine and terbutaline were equieffective. When the tone was increased by phenylephrine, dobutamine and terbutaline caused equivalent relaxations proximally, but distally the relaxation to dobutamine was larger than that to terbutaline.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8103192     DOI: 10.1007/bf00166942

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  19 in total

1.  Beta1 and beta2 receptor mechanisms in rat jugular veins: differences between norepinephrine and isoproterenol-induced relaxation.

Authors:  M L Cohen; K S Wiley
Journal:  Life Sci       Date:  1978-11-13       Impact factor: 5.037

2.  Adrenergic receptors in the veins of the dog.

Authors:  S Guimarães; W Osswald
Journal:  Eur J Pharmacol       Date:  1969-01       Impact factor: 4.432

3.  Alpha 2-adrenoceptor-mediated responses to so-called selective alpha 1-adrenoceptor agonists after partial blockade of alpha 1-adrenoceptors.

Authors:  S Guimarães; M Q Paiva; D Moura
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-04       Impact factor: 3.000

4.  A study of the adrenoceptor-mediated feedback mechanism by using adrenaline as a false transmitter.

Authors:  S Guimarães; F Brandão; M Q Paiva
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1978-11       Impact factor: 3.000

5.  Dobutamine: development of a new catecholamine to selectively increase cardiac contractility.

Authors:  R R Tuttle; J Mills
Journal:  Circ Res       Date:  1975-01       Impact factor: 17.367

6.  Mechanisms of supersensitivity and subsensitivity to sympathomimetic amines.

Authors:  U Trendelenburg
Journal:  Pharmacol Rev       Date:  1966-03       Impact factor: 25.468

7.  Profile of beta-adrenoceptors in femoral, superior mesenteric and renal vascular beds of dogs.

Authors:  N Taira; Y Yabuuchi; S Yamashita
Journal:  Br J Pharmacol       Date:  1977-04       Impact factor: 8.739

8.  Inhibition of catecholamine Uptake-2 by steroids in the isolated rat heart.

Authors:  L L Iversen; P J Salt
Journal:  Br J Pharmacol       Date:  1970-11       Impact factor: 8.739

9.  The effectiveness of alpha 2-adrenoceptor activation increases from the distal to the proximal part of the veins of canine limbs.

Authors:  S Guimaraes; J P Nunes
Journal:  Br J Pharmacol       Date:  1990-10       Impact factor: 8.739

10.  Activation of adenylate cyclase by the diterpene forskolin does not require the guanine nucleotide regulatory protein.

Authors:  K Seamon; J W Daly
Journal:  J Biol Chem       Date:  1981-10-10       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.